Management of leptomeningeal metastases: Prognostic factors and associated outcomes.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of clinical neuroscience

• Publication date

  2016-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jocn.2015.11.012PMID 26778048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.

  2015cited by this paper
• Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

  2014cited by this paper
• Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors

  2014influential reference
• A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer

  2013cited by this paper
• Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience

  2013influential reference
• Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy

  2012cited by this paper
• Neoplastic meningitis.

  2011cited by this paper
• Neoplastic meningitis (Journal of Clinical Oncology (2005) 23 (3605-3613))

  2010cited by this paper
• Leptomeningeal Metastasis

  2010cited by this paper
• An Unusual Case of Pancreatic Cancer with Leptomeningeal Infiltration

  2010cited by this paper
• Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

  2009cited by this paper
• Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.

  2009influential reference
• Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.

  2008influential reference
• A randomized phase III/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis.

  2006cited by this paper
• Neoplastic meningitis.

  2006cited by this paper
• Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment.

  2006cited by this paper
• Neoplastic meningitis.

  2005cited by this paper
• The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

  2004cited by this paper
• Leptomeningeal metastasis: survival and prognostic factors in 155 patients.

  2004influential reference
• Radiotherapy of the Neuroaxis for Palliative Treatment of Leptomeningeal Carcinomatosis

  2001cited by this paper
• A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

  1999cited by this paper
• Leptomeningeal metastasis

  1993influential reference
• Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

  1993cited by this paper
• A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.

  1987cited by this paper
• Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients

  1982influential reference
• CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival

  1979cited by this paper

• The Use of Radiotherapy in Leptomeningeal Carcinomatosis: A Systematic Review and Random-Effects Proportions Meta-Analysis.

  2026cites this paper
• Retrospective study of leptomeningeal metastasis: unveiling the indolent and rapid progression phases

  2025cites this paper
• Prognostic factors of meningeal carcinomatosis in breast cancer patients

  2025influential citation
• An unexpected corridor to brain metastasis

  2024cites this paper
• Radiation and Melanoma: Where Are We Now?

  2024cites this paper
• Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss

  2024cites this paper
• Treatment of Leptomeningeal Metastases from Breast Cancer: A Literature Review

  2024cites this paper
• The anatomic basis of leptomeningeal metastasis

  2024cites this paper
• Interdisziplinäre Therapie von Hirnmetastasen

  2024cites this paper
• Individual survival prediction model for patients with leptomeningeal metastasis.

  2024cites this paper
• Evaluating the efficacy and safety of single-agent etoposide intra-CSF chemotherapy in children and young people with relapsed/refractory central nervous system tumours

  2023cites this paper
• Multidisciplinary management of HER2-positive breast cancer with brain metastases: An evidence-based pragmatic approach moving from pathophysiology to clinical data.

  2023cites this paper
• Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial

  2023cites this paper
• Diagnostic and Therapeutic Updates in Leptomeningeal Disease

  2023cites this paper
• Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis

  2023influential citation
• Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases

  2023cites this paper
• Recent Advances and Applications of Radiation Therapy for Brain Metastases

  2022cites this paper
• Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery

  2022cites this paper
• Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors

  2022cites this paper
• Radiotherapy for Leptomeningeal Carcinomatosis in Breast Cancer Patients: A Narrative Review

  2022cites this paper
• Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer: A Rare Phenomenon?

  2022influential citation
• Prolonged Survival and Restored Useful Life by Early Induction of Intrathecal Chemotherapy in a Patient with Leptomeningeal Carcinomatosis from Ovarian Cancer

  2022cites this paper
• Leptomeningeal Metastases and Intrathecal Chemotherapy

  2022cites this paper
• A Retrospective Study of Intrathecal Pemetrexed Combined With Systemic Therapy for Leptomeningeal Metastasis of Lung Cancer

  2022cites this paper
• Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology

  2022cites this paper
• Salvage Treatment for Progressive Brain Metastases in Breast Cancer

  2022cites this paper
• Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma

  2022cites this paper
• The Role of Immune Checkpoint Inhibitors in Leptomeningeal Disease: A Systematic Review

  2021cites this paper
• Serum Exosomal miRNA Might Be a Novel Liquid Biopsy to Identify Leptomeningeal Metastasis in Non-Small Cell Lung Cancer

  2021cites this paper
• Brain Metastases: An Update on Multi-disciplinary Approach of Clinical Management.

  2021cites this paper
• Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression

  2021cites this paper
• Leukaemia: a model metastatic disease

  2021cites this paper
• Metástasis leptomeníngea: un caso reportado de cáncer de mama HER2 positivo

  2021cites this paper
• Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches

  2021cites this paper
• Autocrine GMCSF Signaling Contributes to Growth of HER2+ Breast Leptomeningeal Carcinomatosis

  2021cites this paper
• Treatment of Leptomeningeal Metastases: New Hammer, the Same Nail.

  2021cites this paper
• Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

  2021cites this paper
• GM-CSF signaling is critical for HER2+ breast leptomeningeal carcinomatosis

  2020cites this paper
• Leptomeningeal metastases from non-small cell lung cancer: state of the art and recent advances

  2020influential citation
• Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.

  2020cites this paper
• Management of Brain and Leptomeningeal Metastases from Breast Cancer

  2020cites this paper
• Health care resource utilization and treatment of leptomeningeal carcinomatosis in the United States.

  2020cites this paper
• Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy

  2020cites this paper
• Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study

  2020cites this paper
• ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases

  2020cites this paper
• Pattern of loco‐regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution

  2020cites this paper
• Epidemiology and prognosis of ommaya reservoir-related bacterial meningitis in adult patients with leptomeningeal metastases from solid tumors: A 10-year retrospective single-center study in Japan.

  2020cites this paper
• Cases of Breast Cancer-Associated Neoplastic Meningitis and Literature Review

  2020cites this paper
• The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.

  2019cites this paper
• Neuraxis metastases from central nervous system tumors: a review of clinicopathological and radiographic characters of 198 cases in a single center

  2019cites this paper
• Management of leptomeningeal metastases in non-small cell lung cancer

  2019cites this paper
• Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials

  2019cites this paper
• Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report

  2019cites this paper
• Immune Microenvironment of Brain Metastases—Are Microglia and Other Brain Macrophages Little Helpers?

  2019cites this paper
• Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.

  2019cites this paper
• The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non‐small‐cell lung cancer‐a retrospective study from one single cancer institute

  2019cites this paper
• Leptomeningeal Carcinomatosis: A Case Report of Metastatic Triple-negative Breast Adenocarcinoma

  2019cites this paper
• A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.

  2019cites this paper
• Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)

  2019cites this paper
• A rare case of malignant meningitis from a likely bronchogenic melanoma primary cancer

  2019cites this paper
• Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis

  2019influential citation
• Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response

  2019cites this paper
• Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center

  2019influential citation
• CMAR_A_217672 9829..9841

  2019influential citation
• The Evolving Landscape of Brain Metastasis.

  2018cites this paper
• Prognostic Factors in Leptomeningeal Metastasis

  2018influential citation
• A Retrospective Analysis of the Clinical Outcomes of Leptomeningeal Metastasis in Patients with Solid Tumors

  2018cites this paper
• Lactate dehydrogenase as a prognostic marker in neoplastic meningitis.

  2018cites this paper
• Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer

  2018cites this paper
• Great efficacy of bevacizumab plus erlotinib for leptomeningeal metastases from non-small cell lung cancer with initially positive EGFR mutation: a case report

  2018cites this paper
• EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid

  2018cites this paper
• Leptomeningeal metastases in non-small-cell lung cancer.

  2018cites this paper
• Carcinomatous Meningitis from Solid Tumors: A Seven Years’ Experience in Moroccan Patients

  2018cites this paper
• F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

  2018cites this paper
• Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review

  2018cites this paper
• A model of breast cancer meningeal metastases: characterization with in vivo molecular imaging

  2018cites this paper
• A nomogram for predicting survival in patients with breast cancer brain metastasis

  2017cites this paper
• Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature

  2017cites this paper
• Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

  2017cites this paper
• Leptomeningeal metastases of solid cancer.

  2016cites this paper
• Leptomeningeal Metastases in Patients with NSCLC with EGFR Mutations

  2016cites this paper